About Roger D'Orazio
Form D filings for BlueWillow Biologics from 2022 to 2024 list Roger D'Orazio as director.
Roger D'Orazio first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Roger D'Orazio in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Roger D'Orazio works with at each company, as listed on that company's latest Form D.
BlueWillow Biologics, Inc. · Form D, Feb 12, 2024
PW
Phil Wilmington
Director
DS
David Stout
Director
GA
George Arida
Executive officer
HB
Hugo Braun
Director
CC
Chad Costley
President & Chief Executive Officer, director